The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants

Journal of Parenteral and Enteral Nutrition

Volumn 32, Issue 4, 2008, Pages 443-447

  Paauw, James D ^a   Borders, Heather ^b   Ingalls, Nichole ^b   Boomstra, Sarah ^a   Lambke, Susan ^a   Fedeson, Brian ^a,b   Goldsmith, Austin ^b   Davis, Alan T ^b,c  

^a SPECTRUM HEALTH   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Anticoagulant; PICC; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ESTROGEN;

ADULT; ARTICLE; BODY MASS; CALCULATION; CANCER PATIENT; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SMOKING; VEIN THROMBOSIS;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 45749141661     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108319801     Document Type: Article

References (36)

1. Kasio K. A short history of central venous catheterization. Acta Anesethiol Scand. 1985 ; 81: 7-10.
2. Hoshal VL Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters. Arch Surg. 1975 ; 110: 644-646.
3. Ng PK, Ault MJ, Ellrodt AG, Maldonado L. PICCs in general medicine. Mayo Clin Proc. 1997 ; 72: 225-233.
4. Cardella JF, Cardella K., Bacci N., Fox PS, Post JH Cumulative experience with 1273 peripherally inserted central catheters at a single institution. J Vasc Interv Radiol. 1996 ; 7: 5-13.
5. Loughran SC, Borzatta M. PICCs: a report of 2506 catheter days. JPEN J Parenteral Enteral Nutr. 1995 ; 19: 1330-1336.
6. Miller KD, Dietrick CL Experience with PICC at a university medical center. J Intraven Nurs. 1997 ; 20: 141-147.
7. Pradoni P., Polistene P., Bemardi E., et al. Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications. Arch Intern Med. 1997 ; 157: 57-62.
8. Paz-Famagalli R., Miller YA, Russell BA, Crain MR, Beres RA, Mewissen MW Impact of peripherally inserted central catheters on phlebitic complications of peripheral intravenous therapy in spinal cord injury patients. J Spinal Cord Med. 1997 ; 20 (S). 341-344.
9. Bernardi E., Piccioli A., Marchiori A., Girolami B., Prandoni P. Upper extremity deep vein thrombosis: risk factors, diagnosis, and management. Semin Vasc Med. 2001 ; 1 (1). 105-110.
10. Schmittling ZC, McLafferty RB, Bohannon WT, Ramsey DE, Hodgson KJ Characterization and probability of upper extremity deep venous thrombosis. Ann Vasc Surg. 2004 ; 18: 552-557.
11. Chemaly RF, de Parres JB, Rehm SJ, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002 ; 34: 1179-1183.
12. Cortelezzi A., Frachiolla NS, Maisonneuve P., et al. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma. 2003 ; 44: 1495-1501.
13. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis. Chest. 1998 ; 113: 165-171.
14. Verso M., Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003 ; 21: 3665-3675.
15. Murphy PT, O'Connor N. Low risk of central venous thrombosis with nontunnelled central venous catheters. Clin Lab Haem. 2001 ; 23: 187-188.
16. Koksoy C., Kuzu A., Erden I., Akkaya A. The risk factors in central venous catheter-related thrombosis. Aust NZ J Surg. 1995 ; 65: 796-798.
17. Wu X., Studer W., Skarvan K., Seeberger M. High incidence of intravenous thrombi after short-term central venous catheterization of the internal jugular vein. J Clin Anesth. 1999 ; 11: 482-485.
18. Karnik R., Valentin A., Winkler W-B., Donath P., Slany J. Duplex sonographic detection of internal jugular venous thrombosis after removal of central venous catheters. Clin Cardiology. 1993: 16: 26-29.
19. Ross A., Griffith C., Anderson J. Thromboembolic complications with silicone elastomer subclavian catheters. JPEN J Parenter Enteral Nutr. 1982 ; 6: 61-63.
20. Eastbridge BJ, Lefor AT Complications of indwelling intravenous catheter devices in cancer patients. J Clin Oncol. 1995 ; 13: 233-238.
21. Grove JR, Pevec WC Venous thrombosis related to peripherally inserted catheters. J Vasc Interv Radiology. 2000 ; 11: 837-840.
22. Walshe LJ, Malak SF, Eagan J., Sepkowitz KA Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002 ; 20: 3276-3281.
23. Elliot G. Upper-extremity deep vein thrombosis. Lancet. 1997 ; 349: 1188-1189.
24. Fraser JD, Anderson DR Deep venous thrombosis: recent advances and optimal investigation with US. Radiology. 1999 ; 211: 9-24.
25. Bern HM, Lokich JJ, Wallach SR, et al. Very low dose of warfarin can prevent thrombosis in central venous catheters: a randomized, prospective trial. Ann Intern Med. 1990 ; 112: 423-428.
26. Boraks P., Seale J., Price J., et al. Prevention of central venous catheter-associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol. 1998 ; 101: 483-486.
27. Monreal M., Alastrue A., Rull M., et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices: prophylaxis with a low-molecular weight heparin (Fragmin). Thromb Haemost. 1996 ; 75: 251-253.
28. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest. 1996 ; 113: 165-171.
29. Mismetti P., Mille D., Laporte S., et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica. 2003 ; 88: 67-73.
30. Klerk CPW, Smorenburg SM, Buller HR Thrombosis prophylaxis in patient populations with a central venous catheter. A systematic review. Arch Intern Med. 2003 ; 163: 1913-1921.
31. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: prophylaxis in medical patients with enoxaparin study group. N Engl J Med. 1999 ; 341: 793-800.
32. Vaitkus PT, Leizorovicz A., Goldhaber SZ PREVENT investigator group. Vasc Med. 2002 ; 7: 269-273.
33. Horattas MC, Wright DJ, Fenton AH, et al. Changing concepts of deep vein thrombosis of the upper extremity. Report of a series and review of the literature. Surgery. 1988 ; 104: 561-567.
34. Marie I., Levesque H., Cailleaux N., et al. Deep vein thrombosis of the upper limbs: apropos of 49 cases. Rev Med Interne. 1998 ; 19: 399-408.
35. Monreal M., Raventos A., Lerma R., et al. Pulmonary embolism in patients with upper extremity deep vein thrombosis associated to central venous lines: a prospective study. Thromb Haemos. 1994 ; 72: 548-550.
36. Kooi JD, vander Zant FM, van Beek EJ, Reekers JA Pulmonary embolism in deep vein thrombosis of the upper extremity: more often in catheter-related thrombosis. Neth J Med. 1997: 50: 238-242.